Yuan Mao

1.3k total citations
58 papers, 946 citations indexed

About

Yuan Mao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yuan Mao has authored 58 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Oncology and 16 papers in Immunology. Recurrent topics in Yuan Mao's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunotherapy and Immune Responses (7 papers). Yuan Mao is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunotherapy and Immune Responses (7 papers). Yuan Mao collaborates with scholars based in China, United States and Czechia. Yuan Mao's co-authors include Jin Zhu, Dawei Zhang, Xiaojun Tang, Lin Xiong, Qi Tang, Renjie Chen, Weifei Fan, Qing Cao, Ning Xu and Hong Lin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yuan Mao

55 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Mao China 20 497 445 266 152 126 58 946
Lizhou Jia China 19 468 0.9× 433 1.0× 224 0.8× 265 1.7× 81 0.6× 45 968
Hyung‐Gyoon Kim United States 17 541 1.1× 405 0.9× 197 0.7× 189 1.2× 58 0.5× 33 1.0k
David Killock United States 13 345 0.7× 344 0.8× 214 0.8× 146 1.0× 54 0.4× 211 879
Björn Schneider Germany 22 502 1.0× 242 0.5× 137 0.5× 174 1.1× 162 1.3× 63 1.2k
Xuhui Bao United States 14 475 1.0× 357 0.8× 396 1.5× 240 1.6× 56 0.4× 32 1.1k
Keegan Barry-Holson United States 8 521 1.0× 403 0.9× 447 1.7× 135 0.9× 65 0.5× 11 1.3k
Christine Gjerdrum Norway 3 514 1.0× 488 1.1× 385 1.4× 158 1.0× 67 0.5× 6 1.1k
Seong Hoe Park South Korea 16 393 0.8× 351 0.8× 329 1.2× 97 0.6× 139 1.1× 24 906
Nuran Bektas Germany 13 642 1.3× 269 0.6× 206 0.8× 132 0.9× 79 0.6× 15 1.0k
Elisa Melucci Italy 18 421 0.8× 465 1.0× 144 0.5× 244 1.6× 56 0.4× 31 871

Countries citing papers authored by Yuan Mao

Since Specialization
Citations

This map shows the geographic impact of Yuan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Mao more than expected).

Fields of papers citing papers by Yuan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Mao. The network helps show where Yuan Mao may publish in the future.

Co-authorship network of co-authors of Yuan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Mao. A scholar is included among the top collaborators of Yuan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Mao. Yuan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Yuan, et al.. (2024). Suppression of AGRN enhances CD8 + T cell recruitment and inhibits breast cancer progression. The FASEB Journal. 38(7). e23582–e23582. 2 indexed citations
2.
Sun, Haijun, et al.. (2024). The expression characteristic and prognostic role of Siglec‐15 in lung adenocarcinoma. The Clinical Respiratory Journal. 18(5). e13772–e13772. 1 indexed citations
3.
Shen, Hongyu, et al.. (2024). Exosomal circRHCG promotes breast cancer metastasis via facilitating M2 polarization through TFEB ubiquitination and degradation. npj Precision Oncology. 8(1). 22–22. 12 indexed citations
4.
Mao, Yuan, Yufeng Chen, Xiao‐Hui Yang, et al.. (2024). Construction and characterization of a novel secreted MsC-CAR-T cell in solid tumors. Cancer Letters. 611. 217382–217382. 3 indexed citations
5.
Bai, Yongkang, Xiang Liu, Li‐Min Zheng, et al.. (2023). Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors. Neoplasia. 38. 100888–100888. 5 indexed citations
6.
Li, Jia, Yuan Mao, Bo Sheng, et al.. (2022). The SP-ET index is a new index for assessing the vertical position of patella. Insights into Imaging. 13(1). 152–152. 1 indexed citations
7.
8.
Gu, Xuefeng, Yuan Mao, Chuanbing Shi, et al.. (2019). <p>MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition</p>. OncoTargets and Therapy. Volume 12. 7843–7855. 6 indexed citations
9.
Yang, Shu, Xuefeng Gu, Hongyu Shen, et al.. (2019). SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma. Experimental and Molecular Pathology. 110. 104276–104276. 11 indexed citations
10.
Wang, Lin, Suyao Liu, Yuan Mao, et al.. (2018). CircRNF13 regulates the invasion and metastasis in lung adenocarcinoma by targeting miR-93-5p. Gene. 671. 170–177. 29 indexed citations
11.
Wang, Jun, Wei Li, Weifei Fan, et al.. (2018). COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells. Biomedicine & Pharmacotherapy. 103. 373–380. 31 indexed citations
12.
Zhang, Huilin, Huijun Zhu, Xudong Wang, et al.. (2014). High APRIL expression correlates with unfavourable survival of gastrointestinal stromal tumour. Pathology. 46(7). 617–622. 15 indexed citations
13.
Zhang, Huilin, et al.. (2014). The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma. Molecular and Cellular Biochemistry. 391(1-2). 77–84. 9 indexed citations
14.
Zhang, Huilin, Jinrong Qiu, Ling-juan Gao, et al.. (2014). ROR1 expression correlated with poor clinical outcome in human ovarian cancer. Scientific Reports. 4(1). 5811–5811. 93 indexed citations
15.
Chen, Renjie, Jun Wang, Dawei Zhang, et al.. (2013). Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(5). 713–719. 25 indexed citations
16.
17.
Mao, Yuan, Mei Lü, Hong Lin, et al.. (2013). Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies. PLoS ONE. 8(4). e60313–e60313. 9 indexed citations
18.
Zhu, Huijun, Xudong Wang, Huilin Zhang, et al.. (2013). Upregulated ZO-1 correlates with favorable survival of gastrointestinal stromal tumor. Medical Oncology. 30(3). 631–631. 22 indexed citations
19.
Mao, Yuan, Dawei Zhang, Hong Lin, et al.. (2012). Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 31(1). 101–101. 38 indexed citations
20.
Mao, Yuan, Dawei Zhang, Huijun Zhu, et al.. (2012). LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL). Diagnostic Pathology. 7(1). 178–178. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhou Jia Breakdown of academic impact, for papers by Hyung‐Gyoon Kim Breakdown of academic impact, for papers by David Killock Breakdown of academic impact, for papers by Björn Schneider Breakdown of academic impact, for papers by Xuhui Bao Breakdown of academic impact, for papers by Keegan Barry-Holson Breakdown of academic impact, for papers by Christine Gjerdrum Breakdown of academic impact, for papers by Seong Hoe Park Breakdown of academic impact, for papers by Nuran Bektas Breakdown of academic impact, for papers by Elisa Melucci
Rankless by CCL
2026